Journal
CARCINOGENESIS
Volume 42, Issue 12, Pages 1449-1460Publisher
OXFORD UNIV PRESS
DOI: 10.1093/carcin/bgab101
Keywords
-
Categories
Funding
- EPIGEN Flagship Project (EPIGEN-CNR-IT)
- Italian Association for Cancer Research [IG-23068]
- Regione Campania (POR Campania FESR 2014/2020) [CUP:B41C17000080007]
- EU H2020 MSCA-RISE project diaRNAgnosis [101007934]
- Fondazione CARITRO
- University of Trento, Department CIBIO
Ask authors/readers for more resources
The study demonstrates that the interaction between DNMT3A and miRNAs plays a central role in the EMT process of prostate cancer, with key miRNAs such as the miR-200 family, miR-205, and miR-203 being down-regulated and hyper-methylated. Differential expression of DNMT3A isoforms and a regulatory feedback loop between miR-429 and DNMT3A were also identified during EMT. Additionally, miR-429 was shown to target DNMT3A and modulate the expression of EMT factors.
Epithelial-to-mesenchymal transition (EMT) is involved in prostate cancer (PCa) metastatic progression, and its plasticity suggests epigenetic implications. Deregulation of DNA methyltransferases (DNMTs) and several microRNAs (miRNAs) plays a relevant role in EMT, but their interplay has not been clarified yet. In this study, we provide evidence that DNMT3A interaction with several miRNAs has a central role in an ex vivo EMT PCa model obtained via exposure of PC3 cells to conditioned media from cancer-associated fibroblasts. The analysis of the alterations of the miRNA profile shows that miR-200 family (miR-200a/200b/429, miR-200c/141), miR-205 and miR-203, known to modulate key EMT factors, are down-regulated and hyper-methylated at their promoters. DNMT3A (mainly isoform a) is recruited onto these miRNA promoters, coupled with the increase of H3K27me3/H3K9me3 and/or the decrease of H3K4me3/H3K36me3. Most interestingly, our results reveal the differential expression of two DNMT3A isoforms (a and b) during ex vivo EMT and a regulatory feedback loop between miR-429 and DNMT3A that can promote and sustain the transition towards a more mesenchymal phenotype. We demonstrate the ability of miR-429 to target DNMT3A 3'UTR and modulate the expression of EMT factors, in particular ZEB1. Survey of the PRAD-TCGA dataset shows that patients expressing an EMT-like signature are indeed characterized by down-regulation of the same miRNAs with a diffused hyper-methylation at miR-200c/141 and miR-200a/200b/429 promoters. Finally, we show that miR-1260a also targets DNMT3A, although it does not seem to be involved in EMT in PCa.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available